
effiScience HealthCare helps pharmaceutical companies identify optimal indications and minimize adverse effects for a treatment, by detecting and explaining all groups of patients - which are not detected using existing methods - who respond better than others to a given treatment, or who develop adverse effects. We also help Research institutions detect and describe unexpected local combinations of factors leading to pathologic conditions or to a significant resistance to these conditions.
These profiles can then be included or eliminated of the target population of a drug leveraging the benefit - risk ratio to optimize the market access.